Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
暂无分享,去创建一个
[1] P. Cryer,et al. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. , 1985, The New England journal of medicine.
[2] W. Kerner,et al. Incidence of Hypoglycemic Episodes in Diabetic Patients Under Continuous Subcutaneous Insulin Infusion and Intensified Conventional Insulin Treatment: Assessment by Means of Semiambulatory 24-hour Continuous Blood Glucose Monitoring , 1985, Diabetes Care.
[3] J. Field,et al. Role of the endocrine pancreas in the kalemic response to acute metabolic acidosis in conscious dogs. , 1985, The Journal of clinical investigation.
[4] J. Palmer,et al. Glucose counterregulation during recovery from neuroglucopenia: which mechanism is important? , 1985, Metabolism: clinical and experimental.
[5] S. Efendić,et al. Impaired counter regulation of hypoglycemia in a group of insulin-dependent diabetics with recurrent episodes of severe hypoglycemia. , 2009, Acta medica Scandinavica.
[6] J. McGarry,et al. The glucose paradox. Is glucose a substrate for liver metabolism? , 1984, The Journal of clinical investigation.
[7] P. Cryer,et al. Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia). , 1984, The New England journal of medicine.
[8] M. Müller,et al. Effect of ketone bodies on glucose production and utilization in the miniature pig. , 1984, The Journal of clinical investigation.
[9] P. Cryer,et al. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. , 1984, The New England journal of medicine.
[10] T. Patel,et al. The stimulation of hepatic gluconeogenesis by acetoacetate precursors. A role for the monocarboxylate translocator. , 1984, The Journal of biological chemistry.
[11] P. Cryer,et al. Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine intera , 1984, The Journal of clinical investigation.
[12] P. Cryer,et al. Oral Propranolol and Metoprolol Both Impair Glucose Recovery from Insulin-induced Hypoglycemia in Insulin-dependent Diabetes Mellitus , 1984, Diabetes Care.
[13] W. Kerner,et al. Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients. , 1984, Metabolism: clinical and experimental.
[14] G. Bolli,et al. The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. , 1984, The New England journal of medicine.
[15] H. Shamoon,et al. Effect of Propranolol on Delayed Glucose Recovery After Insulin-induced Hypoglycemia in Normal and Diabetic Subjects , 1984, Diabetes Care.
[16] S. G. Rosen,et al. Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man. , 1984, The Journal of clinical investigation.
[17] Maria Inês Schmidt,et al. Fasting Early Morning Rise in Peripheral Insulin: Evidence of the Dawn Phenomenon in Nondiabetes , 1984, Diabetes Care.
[18] R. DeFronzo,et al. Effect of fatty acids on glucose production and utilization in man. , 1983, The Journal of clinical investigation.
[19] N. Christensen,et al. Sympathetic nervous activity during exercise. , 1983, Annual review of physiology.
[20] H. Quabbe,et al. Influence of ketone body infusion on plasma growth hormone and glucagon in man. , 1983, The Journal of clinical endocrinology and metabolism.
[21] J. Miller,et al. Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects. , 1983, The Journal of clinical investigation.
[22] P. Cryer,et al. Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion. , 1983, The Journal of clinical investigation.
[23] C. A. Benzo. The hypothalamus and blood glucose regulation , 1983 .
[24] P. Cryer,et al. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. , 1983, The New England journal of medicine.
[25] C. Holmes,et al. A Survey of Cognitive Functioning at Different Glucose Levels in Diabetic Persons , 1983, Diabetes Care.
[26] D. Wilson. Excessive insulin therapy: biochemical effects and clinical repercussions. Current concepts of counterregulation in type I diabetes. , 1983, Annals of internal medicine.
[27] P. Cryer,et al. Rdevance of Glucose Counterregulatory Systems to Patients with Diabetes: Critical Roles of Glucagon and Epinephrine , 1983, Diabetes Care.
[28] A. Cherrington,et al. Glucagon and Liver Glucose Output In Vivo , 1983 .
[29] K. Polonsky,et al. Relation of counterregulatory responses to hypoglycemia in type I diabetics. , 1982, The New England journal of medicine.
[30] J. Potter,et al. Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? , 1982, British medical journal.
[31] W. Millington,et al. Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Hoeldtke,et al. Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. , 1982, Annals of internal medicine.
[33] P. Cryer,et al. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. , 1982, The Journal of clinical investigation.
[34] L. Mandarino,et al. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. , 1982, The Journal of clinical endocrinology and metabolism.
[35] R. Hoeldtke,et al. Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. , 1981, The New England journal of medicine.
[36] M. Rendell,et al. The Dawn Phenomenon, an Early Morning Glucose Rise: Implications for Diabetic Intraday Blood Glucose Variation , 1981, Diabetes Care.
[37] A. Gjedde,et al. Blood-brain glucose transfer: repression in chronic hyperglycemia. , 1981, Science.
[38] W. Tunbridge,et al. FACTORS CONTRIBUTING TO DEATHS OF DIABETICS UNDER FIFTY YEARS OF AGE , 1981, The Lancet.
[39] N. Christensen,et al. Hormonal, Metabolic, and Cardiovascular Responses to Hypoglycemia in Diabetic Autonomic Neuropathy , 1981, Diabetes.
[40] R. Sherwin,et al. Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. , 1981, Journal of Clinical Endocrinology and Metabolism.
[41] P. Cryer. Glucose Counterregulation in Man , 1981, Diabetes.
[42] M. Haymond,et al. Suppression of glucose production and stimulation of insulin secretion by physiological concentrations of ketone bodies in man. , 1981, The Journal of clinical endocrinology and metabolism.
[43] N. Ruderman,et al. Diabetes and exercise. , 1981, The American journal of medicine.
[44] P. Lönnroth,et al. Can insulin-treated diabetics be given beta-adrenergic-blocking drugs? , 1980, British medical journal.
[45] P. Cryer,et al. Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. , 1980, The Journal of clinical endocrinology and metabolism.
[46] R. Tattersall,et al. IN SEARCH OF THE SOMOGYI EFFECT , 1980, The Lancet.
[47] P. Cryer,et al. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. , 1980, The Journal of clinical investigation.
[48] P. Watkins,et al. Can insulin-treated diabetics be given beta-adrenergic blocking drugs? , 1980, British medical journal.
[49] J. Ensinck,et al. Glucagon Responses to Hypoglycemia in Type I Diabetic Men After 24-hour Glucoregulation by Glucose-controlled Insulin Infusion , 1980, Diabetes Care.
[50] R. Rizza,et al. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. , 1980, The Journal of clinical investigation.
[51] R. DeFronzo,et al. Epinephrine-induced insulin resistance in man. , 1980, The Journal of clinical investigation.
[52] W. Lautt. Hepatic nerves: a review of their functions and effects. , 1980, Canadian journal of physiology and pharmacology.
[53] A. Vinik,et al. Studies on Plasma Glucagon Concentration in Maturity-Onset Diabetics with Autonomic Neuropathy , 1979, Diabetes.
[54] M. Rendell,et al. Fasting Hyperglycemia and Associated Free Insulin and Cortisol Changes in “Somogyi-Like” Patients , 1979, Diabetes Care.
[55] P. Ferré,et al. Interactions in vivo between oxidation of non-esterified fatty acids and gluconeogenesis in the newborn rat. , 1979, The Biochemical journal.
[56] R. Rizza,et al. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. , 1979, The Journal of clinical investigation.
[57] R. Sherwin,et al. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. , 1979, The Journal of clinical investigation.
[58] U. Smith,et al. EFFECT OF CARDIOSELECTIVE AND NON-SELECTIVE β-BLOCKADE ON THE HYPOGLYCÆMIC RESPONSE IN INSULIN-DEPENDENT DIABETICS , 1979, The Lancet.
[59] A. Cherrington,et al. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man. , 1979, The Journal of clinical endocrinology and metabolism.
[60] N Eigler,et al. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia. , 1979, The Journal of clinical investigation.
[61] R. Sherwin,et al. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. , 1978, The Journal of clinical endocrinology and metabolism.
[62] G. Shulman,et al. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon. , 1978, The Journal of clinical investigation.
[63] T. Deckert,et al. Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. , 1978, Diabetologia.
[64] E. Kraegen,et al. Defective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy. , 1977, British medical journal.
[65] J. McGarry,et al. Glucagon and ketogenesis. , 1976, Metabolism: Clinical and Experimental.
[66] P. Cryer,et al. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. , 1976, The Journal of clinical investigation.
[67] J. Gerich,et al. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man. , 1974, The Journal of clinical investigation.
[68] E. Hultman,et al. Liver glycogen in man--the effect of total starvation or a carbohydrate-poor diet followed by carbohydrate refeeding. , 1973, Scandinavian journal of clinical and laboratory investigation.
[69] J. Gerich,et al. Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect , 1973, Science.
[70] P. Cryer,et al. Cessation of growth hormone secretion associated with acute elevation of the serum-free fatty acid concentration. , 1972, Metabolism: clinical and experimental.
[71] W. Blackard,et al. Effect of lipids on growth hormone secretion in humans. , 1971, Journal of Clinical Investigation.
[72] D. Mintz,et al. Insulin-induced posthypoglycemic hyperglycemia as a cause of "brittle" diabetes. Clinical clues and therapeutic implications. , 1969, The American journal of medicine.
[73] J. Malins. Clinical Diabetes Mellitus , 1968, Diabetes.
[74] G F Cahill,et al. Brain metabolism during fasting. , 1967, The Journal of clinical investigation.
[75] P. Schollmeyer,et al. Substrate-utilization of the Human Kidney , 1966, Nature.
[76] R. Unger,et al. THE HYPOGLYCEMIC ACTION OF KETONES. II. EVIDENCE FOR A STIMULATORY FEEDBACK OF KETONES ON THE PANCREATIC BETA CELLS. , 1964, The Journal of clinical investigation.
[77] A. Maiolo,et al. CEREBRAL BLOOD FLOW AND METABOLISM IN THERAPEUTIC INSULIN COMA. , 1964, Metabolism: clinical and experimental.
[78] E. Newsholme,et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.
[79] M. Somogyi. Exacerbation of diabetes by excess insulin action. , 1959, The American journal of medicine.